Thrombolytic Treatment of Patients with Acute Ischemic Stroke

  • T. Brott
Conference paper

Abstract

Acute thrombus formation or migration is the principal acute pathologic event for two-thirds or more of ischemic stroke patients angiographically studied within 6 h of symptom onset [1]. Consequently, the potential therapeutic role of thrombolytic agents for ischemic cerebral infarction has evoked considerable interest. Clinical studies have been facilitated by the ability to rapidly exclude patients with hemorrhagic stroke by computed tomography (CT), and investigators have been encouraged by the major clinical benefits demonstrated for thrombolytic therapy in treatment for another acute thrombotic disorder, acute myocardial infarction [2].

Keywords

Placebo Migration Ischemia Heparin Neurol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Fieschi C, Argentino C, Lenzi GL et al. (1989) Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sei 91: 311CrossRefGoogle Scholar
  2. 2.
    Marder VJ, Sherry S (1988) Thrombolytic therapy: current status. N Engl J Med 318: 1512–1585PubMedCrossRefGoogle Scholar
  3. 3.
    Courtheoux P, Theron J, Derlon JM et al. (1986) In situ fibrinolysis in supra-aortic main vessels. J Neuroradiol 13: 111PubMedGoogle Scholar
  4. 4.
    Del Zoppo GJ, Ferbert A, Otis S et al. (1988) Local intraarterial fibrinolytic therapy in acute carotid territory stroke: a pilot study. Stroke 19: 307PubMedCrossRefGoogle Scholar
  5. 5.
    Hacke W, Zeumer H, Ferbert A (1988) Intraarterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 19: 1216PubMedCrossRefGoogle Scholar
  6. 6.
    Mori E, Tabuchi M, Yoshida T et al. (1988) Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19: 802PubMedCrossRefGoogle Scholar
  7. 7.
    Theron J, Courtheoux P, Casasco A et al. (1989) Local intraarterial fibrinolysis in the carotid territory. AJNR 10: 753PubMedGoogle Scholar
  8. 8.
    tPA Acute Stroke Study Group (1990) An open multicenter study of the safety and efficacy of various doses of tPA in patients with acute stroke: a progress report. Stroke 21: 181 (abstr)Google Scholar
  9. 9.
    DeWood MA (1980) Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 303: 897CrossRefGoogle Scholar
  10. 10.
    Del Zoppo GJ, Zeumer H, Harker LA (1986) Thrombolytic therapy in stroke: possibilities and hazards. Stroke 17: 595PubMedCrossRefGoogle Scholar
  11. 11.
    Nenci GG, Gresele P, Taramelli M et al. (1983) Thrombolytic therapy for thromboembolism of vertebrobasilar artery. Angiology 34: 561PubMedCrossRefGoogle Scholar
  12. 12.
    Fujishima M, Omae T, Tanaka K et al. (1986) Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction. Angiology 37: 487PubMedCrossRefGoogle Scholar
  13. 13.
    Sato Y, Mizoguchi K, Sato Y et al. (1986) Anticoagulant and thrombolytic therapy for cerebral embolism of cardiac origin. Kurume Med J 33: 39CrossRefGoogle Scholar
  14. 14.
    Brott TG, Haley EC, Levy D et al. (1990) Safety and potential efficacy of tissue plasminogen activator (tPA) for stroke. Stroke 21: 181 (abstr)Google Scholar
  15. 15.
    Del Zoppo GJ (1989) An open multicenter trial of rt-PA in acute stroke: safety and efficacy. Thromb Haemos 62: 27 (abstr)Google Scholar
  16. 16.
    Pessin MS, Del Zoppo GJ, Estol CE (1990) Thrombolytic agents in the treatment of stroke. Clin Neuropharmacol 13: 271PubMedCrossRefGoogle Scholar
  17. 17.
    Price TR (1990) Stroke in patients treated with thrombolytic therapy for acute myocardial infarction. Stroke 21 [Suppl III]: III-8-III-9Google Scholar
  18. 18.
    Koudstaal PJ, Stibbe J, Vermeulen M (1988) Fatal ischemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. Br Med J 297: 1571CrossRefGoogle Scholar
  19. 19.
    Ellis SG, Topol EJ, George BS et al. (1989) Recurrent ischemia without warning: analysis of risk factors for in-hospital ischemic events following successful thrombolysis with intravenous tissue plasminogen activator. Circulation 80: 1159PubMedCrossRefGoogle Scholar
  20. 20.
    Tomsick T, Brott T, Barsan W et al. (1990) Thrombus localization with emergency cerebral computed tomography. Stroke 21: 180 (abstr)Google Scholar
  21. 21.
    Krayenbuhl HA (1967) Cerebral venous and sinus thrombosis. Clin Neurosurg 14: 1Google Scholar
  22. 22.
    Vines FS, Davis DO (1971) Clinical-radiological correlation in cerebral venous occlusive disease. Radiology 98: 9PubMedCrossRefGoogle Scholar
  23. 23.
    Gettelfìnger DM, Kokmen E (1977) Superior sagittal sinus thrombosis. Arch Neurol 34: 2PubMedCrossRefGoogle Scholar
  24. 24.
    Castaigne P, Laplane D, Bousser MP (1977) Superior sagittal sinus thrombosis. Arch Neurol 34: 788 (letter)Google Scholar
  25. 25.
    DiRocco C, Iannelli A, Leone G et al. (1981) Heparin-urokinase treatment in aseptic durai sinus thrombosis. Arch Neurol 38: 431CrossRefGoogle Scholar
  26. 26.
    Zeumer H (1985) Vascular recanalizing techniques in interventional neuroradiology. J Neurol 231: 287PubMedCrossRefGoogle Scholar
  27. 27.
    Scott JA, Pascuzzi RM, Hall PV et al. (1988) Treatment of durai sinus thrombosis with local urokinase infusion. J Neurosurg 68: 284PubMedCrossRefGoogle Scholar
  28. 28.
    Barnwell SL, Halbach VV, Dowd CF et al. (1990) Endovascular thrombolytic therapy for durai sinus thrombosis. J Neurosurg 72: 336AGoogle Scholar
  29. 29.
    Persson L, Lilja A (1990) Extensive durai sinus thrombosis treated by surgical removal and local streptokinase infusion. Neurosurgery 26: 117PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • T. Brott
    • 1
  1. 1.Department of NeurologyUniversity of Cincinnati College of MedicineCincinnatiUSA

Personalised recommendations